NF1 and malignant peripheral nerve sheath tumor: Notably, the in vitro potency of combined type 2 C/BRAFi and MEKi is not obvious in NF1 wild type (WT) human Schwann cells, the cell lineage to MPNST, suggesting that NF1-deficient MPNST are uniquely sensitive to this combination strategy.